Review of gemcitabine in biliary tract carcinoma

被引：56
作者：
Scheithauer, W [1 ]
机构：
[1] Univ Vienna, Dept Internal Med 1, Div Oncol, Sch Med, A-1090 Vienna, Austria
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期
关键词：
D O I：
10.1016/S0093-7754(02)70025-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 45
页数：6
相关论文
共 39 条
  • [1] ANDRE T, 2001, EJC SUPPL, V37, P19
  • [2] ARROYO G, 2001, P AN M AM SOC CLIN, V20, pA626
  • [3] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
    Burris, HA
    Moore, MJ
    Andersen, J
    Green, MR
    Rothenberg, ML
    Madiano, MR
    Cripps, MC
    Portenoy, RK
    Storniolo, AM
    Tarassoff, P
    Nelson, R
    Dorr, FA
    Stephens, CD
    VanHoff, DD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2403 - 2413
  • [4] CARRARO S, 2001, P AN M AM SOC CLIN, V20, pA2333
  • [5] Castro MP, 1998, CANCER, V82, P639, DOI 10.1002/(SICI)1097-0142(19980215)82:4<639::AID-CNCR4>3.0.CO
  • [6] 2-G
  • [7] CSOKA K, 1995, SEMIN ONCOL, V22, P47
  • [8] Medical progress - Biliary tract cancers
    de Groen, PC
    Gores, GJ
    LaRusso, NF
    Gunderson, LL
    Nagorney, DM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (18) : 1368 - 1378
  • [9] DESTOLL M, 1785, RATIONIS MENDENDI 1
  • [10] Dobrila-Dintinjana R., 2000, American Journal of Gastroenterology, V95, P2476
1234